ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2124

Characteristics of Medicare Beneficiaries Travelling Long Distances to Visit a Rheumatologist

Gabriela Schmajuk1, Chris Tonner2 and Jinoos Yazdany3, 1Medicine / Rheumatology, UCSF / San Francisco VA, San Francisco, CA, 23333 California Street, Box 09, University of California, San Francisco, San Francisco, CA, 3Medicine, University of California, San Francisco, San Francisco, CA

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Workforce and access to care

  • Tweet
  • Email
  • Print
Session Information

Title: Health Services Research

Session Type: Abstract Submissions (ACR)

Background/Purpose: Studies of the distribution of rheumatologists across the United States suggest that a significant number of patients travel long distances to visit a rheumatologist.  The geographic, health care market, and patient factors associated with travel distances have not been described.  We examined individual and area-level predictors of travelling long distances to see a rheumatologist.

Methods: Data derive from nationwide Medicare fee-for-service medical claims for 2009 for a 5% random sample of beneficiaries. All patients ≥ age 18 with 12 months of continuous enrollment in Medicare Parts A and B who had at least 1 visit to a rheumatologist were included. We calculated distance between the center of the patient’s 5-digit ZIP code and the center of the rheumatologist’s office 5-digit ZIP code for the first rheumatologist seen during the calendar year.  We compared the characteristics of patients travelling ≥ 50 miles to see a rheumatologist to all others based on sociodemographic (age, sex, race, dual Medicare/Medicaid eligibility, and state buy-in, a measure of personal income) and area-level variables (ZIP-code level socioeconomic status, state-level supply of rheumatologists per 100,000 residents, state-level price-adjusted total Medicare spending per person).  Two percent of observations were censored due to missing data. Included variables were tested for noncolinearity. We used general estimating equations to adjust for individual and area level characteristics in a single multivariate model.

Results: We studied 42,571 Medicare patients who had at least one visit to a rheumatologist during 2009. Median distance traveled was 9.3 miles (IQR 4-22); 9% of patients travelled ≥50 miles to see a rheumatologist. Patients who travelled ≥50 miles were more likely to be younger (age 70.7 vs. 73.3) male (25% vs 20%), White (92% vs. 88%), and live in a low-SES ZIP code (40% vs. 21%). They were also more likely to reside in regions with the lowest supply of rheumatologists (34% vs. 23%). In the adjusted model, the effects of age, sex, race, area-level SES, and rheumatologist supply remained significant although area-level SES had the strongest effect (Table).

Conclusion: Patients travelling very long distances to visit a rheumatologist are more likely to be male, White, and live in lower-SES areas compared to patients travelling less far. Sociodemographic effects are at least as strong as the effect of low rheumatologist supply. These findings suggest that interventions beyond increasing the number of rheumatologists in low supply areas will be necessary to reduce travel distances and improve access to rheumatology care in the U.S.


Disclosure:

G. Schmajuk,
None;

C. Tonner,
None;

J. Yazdany,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/characteristics-of-medicare-beneficiaries-travelling-long-distances-to-visit-a-rheumatologist/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology